权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Arsenic related cystic fibrosis

砷相关的囊性纤维化

基本信息

批准号：
10088446
负责人：
Maitreyi Mazumdar
金额：
$ 36.46万
依托单位：
BOSTON CHILDREN'S HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-02-01 至 2023-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10088446
关键词：
Adult Antibiotics Area Arsenic Arsenic Poisoning Bangladesh Bangladeshi Biochemical Biochemical Pathway Biological Blood Bronchiectasis Cell Culture Techniques Chest Chloride Channels Chlorides Cohort Studies Country Cystic Fibrosis Cystic Fibrosis Transmembrane Conductance Regulator Data Development Diabetes Mellitus Diagnostic Disease Disease Resistance Environmental Exposure Enzyme-Linked Immunosorbent Assay Epidemic European Exhibits Exposure to Fat-Soluble Vitamin Forced expiratory volume function Functional disorder Genetic Diseases Goals Health Human Impairment Individual Insulin Insulin Resistance Intervention Intracellular Fluid Islet Cell Islets of Langerhans Lead Link Lung Lung diseases Measures Mediating Mediation Morbidity - disease rate Mutation Nail plate Obstruction Organ Oxidative Stress Pancreas Pancreatic duct Peripheral Blood Mononuclear Cell Pharmaceutical Preparations Physical therapy Pneumonia Population Pulmonary Function Test/Forced Expiratory Volume 1 Pulmonary function tests Regulator Genes Research Research Design Research Project Grants Respiratory Signs and Symptoms Respiratory physiology Risk Rural Sweat test Symptoms Techniques Testing Therapeutic Intervention Toxic effect Western Blotting cell type contaminated drinking water diabetes risk drinking water early screening epidemiology study experience exposed human population first-in-human glucose tolerance high risk insulin secretion member monocyte mortality novel peripheral blood persistent symptom preventive intervention pulmonary function screening study population systemic inflammatory response

项目摘要

PROJECT SUMMARY/ABSTRACT Environmental arsenic exposure is associated with increased rates of pneumonia, bronchiectasis, and diabetes. The underlying biochemical pathways that link arsenic exposure to lung disease and diabetes are difficult to study, but the symptoms of arsenic toxicity overlap with those of cystic fibrosis, a rare autosomal recessive disease most common in people of Northern European ancestry. Accumulating evidence suggests that arsenic toxicity and cystic fibrosis share a common mechanism: dysfunction of the cystic fibrosis transmembrane regulator (CFTR). CFTR is a chloride channel that regulates intracellular fluid transport in the lungs, pancreas, and other organs. Studies in cell culture show that arsenic causes degradation of CFTR, and our recent epidemiological study demonstrates that humans exposed to arsenic also exhibit CFTR dysfunction. It is critical to understand these specific mechanisms in order to develop effective preventive and therapeutic interventions. In this proposal, we plan to study whether CFTR dysfunction in adults with high arsenic exposure contributes to diminished lung function and diabetes. We propose a comprehensive set of studies that leverage an established study population in rural Bangladesh, a country that is currently experiencing an epidemic of arsenic poisoning through contaminated drinking water. We hypothesize that arsenic influences diminished lung function and risk of diabetes by inducing CFTR dysfunction. We will use established biochemical techniques, including sweat test and Western Blot of peripheral blood mononuclear cells, to assess CFTR function. In this application, we present preliminary data that suggest that sweat chloride, a noninvasive measure that is easy to obtain, is elevated among individuals with high arsenic exposure. We will now test whether sweat chloride concentration can be used to identify individuals at higher risk for low respiratory function and diabetes related to arsenic exposure. Our analyses will employ causal mediation analysis to investigate whether diseases related to arsenic can be attributed to CFTR dysfunction. These studies explore mechanisms by which arsenic may increase risk of lung disease and diabetes in humans, and use a unique population of adults with high arsenic exposure in order to test hypotheses. Our long-range goals are to develop novel screening strategies to identify populations at high risk for lung disease and diabetes due to environmental exposure, and to direct the development of more effective preventive interventions.

项目总结/文摘